A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants with Advanced Tumors Who Are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab

  • Strickland, Andrew (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

Effective start/end date28/09/2127/09/26


  • phase 3 clinical trial
  • treatment efficacy
  • treatment safety
  • advanced tumours